Where I see patients (1)
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.
Pediatric blood & cancer
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adole...
The primary objective of this study is the two Year Event-free Survival for patients with high-risk or recurrent B-ALL who proceed to HCT and who are NGS-MRD negative when treated with a non-TBI preparative regimen.